GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

United American Healthcare UAHC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2015FY2025

Net income

$7,000

FY2015FY2025

Free cash flow

—

FY2015FY2025

Shareholders' equity

$1.1m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Revenue———————$10.7m$8.9m$9.0m
Research and development—————$115,000$194,000———
Operating income−$30,000−$80,000−$67,000−$85,000−$220,000−$213,000−$767,000$898,000$35,000$87,000
Net income$7,000$238,000$723,000−$188,000−$4,000−$2.6m−$29.0m$10.9m$1.4m−$822,000
Diluted earnings per share0.000.000.01-0.00-0.00-0.02-0.250.070.02-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Total assets$1.2m$1.2m$10.4m$9.6m$10.2m$16.7m$22.0m$25.1m$9.3m$9.0m
Cash and short-term investments$308,000$374,000$9.3m$8.5m$6.8m$14.7m$1.5m———
Total liabilities$33,000$89,000$119,000$51,000$139,000$6.7m$50.4m$19.4m$19.9m$20.9m
Debt——————$1.1m$13.5m$14.4m$15.9m
Shareholders' equity$1.1m$1.1m$10.3m$9.6m$10.1m$10.0m−$28.4m$5.7m−$10.5m−$11.9m
Shares outstanding117m117m117m117m117m120m117m146m70m117m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Cash from operations——$867,000$2.8m−$6.6m$705,000$2.2m$632,000$1.5m$1.0m
Capital spending——−$7,000−$846,000—−$40,000−$19,000−$188,000−$361,000−$206,000
Free cash flow——$860,000$1.9m−$6.6m$665,000$2.1m$444,000$1.1m$838,000

Latest quarters

By quarter end

Mar 2025Mar 2024Jun 2023Mar 2023Dec 2022Jun 2022Mar 2022Dec 2021
Operating income−$14,000−$14,000−$30,000−$33,000−$33,000−$40,000−$23,000−$23,000
Net income−$87,000$98,000$500,000$57,000$57,000−$191,000−$24,000−$24,000
Diluted earnings per share-0.000.000.000.000.00-0.00-0.00-0.00
Total assets$1.2m$10.4m$10.2m$9.7m$9.7m$9.7m$10.0m$10.0m
Cash and short-term investments$373,000$9.4m$8.6m$8.6m$8.6m$7.1m$6.7m$6.7m
Shareholders' equity$1.1m$10.4m$10.1m$9.6m$9.6m$9.6m$10.0m$10.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-29.3%-32.4%-23.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings157.71.50.1-0.8-2.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return305%204%-29%995%216%186%297%-69%698%583294%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 6 Sept 2024.

FY2024
Paid in the year0.001

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.